Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noémie Lang

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Revue Medicale Suisse|May 18, 2022
[The rise of the lymphocyte clones: targeted agents strike back]Marc Weiner, Noémie Lang
Revue Medicale Suisse|May 17, 2023
[Post-transplant lymphoproliferative disorders]Sabrina Forsell, Noémie Lang
Revue Medicale Suisse|May 16, 2019
[Monoclonal gammopathies: from MGUS to multiple myeloma]Laure Thouvenin, Noémie Lang
Blood|November 18, 2021
Don't judge lymphocytosis by its flowNoémie Lang, Alexa Samantha Green
Biomedicines|August 26, 2022
CAR T-Based Therapies in Lymphoma: A Review of Current Practice and PerspectivesSemira Sheikh, Denis Migliorini, Noémie Lang
Revue Medicale Suisse|March 15, 2018
[Fertility and cancer in young adults : cured, but what about having children ?]Marie-Estelle Gaignard, Julie Bénard, Noémie Lang
Frontiers in Oncology|March 15, 2024
Case report: From sequence to solution: tailoring treatment for transformed follicular lymphoma (DLBCL) through next generation sequencing studyAntonin Bouroumeau, Sarah Perdikis-Prati, Noémie Lang
Praxis|September 18, 2014
[Progressive cutaneous and pulmonary lesions without infectious etiology: two cases reports of sweet syndrome with pulmonary involvement]Noémie Lang, Maxime Vernez, Peter Vollenweider, et al.
Biomedicines|June 28, 2023
Efficacy of Immune Checkpoint Blockade and Biomarkers of Response in Lymphoma: A Narrative ReviewSarah Perdikis-Prati, Semira Sheikh, Antonin Bouroumeau, et al.
Exploration of Targeted Anti-Tumor Therapy|January 19, 2023
Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidencesMarilia Barreca, Noémie Lang, Chiara Tarantelli, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Revue Medicale Suisse|May 18, 2022
[The rise of the lymphocyte clones: targeted agents strike back]Marc Weiner, Noémie Lang
Revue Medicale Suisse|May 17, 2023
[Post-transplant lymphoproliferative disorders]Sabrina Forsell, Noémie Lang
Revue Medicale Suisse|May 16, 2019
[Monoclonal gammopathies: from MGUS to multiple myeloma]Laure Thouvenin, Noémie Lang
Blood|November 18, 2021
Don't judge lymphocytosis by its flowNoémie Lang, Alexa Samantha Green
Biomedicines|August 26, 2022
CAR T-Based Therapies in Lymphoma: A Review of Current Practice and PerspectivesSemira Sheikh, Denis Migliorini, Noémie Lang
Revue Medicale Suisse|March 15, 2018
[Fertility and cancer in young adults : cured, but what about having children ?]Marie-Estelle Gaignard, Julie Bénard, Noémie Lang
Frontiers in Oncology|March 15, 2024
Case report: From sequence to solution: tailoring treatment for transformed follicular lymphoma (DLBCL) through next generation sequencing studyAntonin Bouroumeau, Sarah Perdikis-Prati, Noémie Lang
Praxis|September 18, 2014
[Progressive cutaneous and pulmonary lesions without infectious etiology: two cases reports of sweet syndrome with pulmonary involvement]Noémie Lang, Maxime Vernez, Peter Vollenweider, et al.
Biomedicines|June 28, 2023
Efficacy of Immune Checkpoint Blockade and Biomarkers of Response in Lymphoma: A Narrative ReviewSarah Perdikis-Prati, Semira Sheikh, Antonin Bouroumeau, et al.
Exploration of Targeted Anti-Tumor Therapy|January 19, 2023
Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidencesMarilia Barreca, Noémie Lang, Chiara Tarantelli, et al.
Pageof 2